Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bayram, Safak (1) Beule, Dieter Dr. (3) Blüthgen, Nils (2) Burkert, Christian Martin (1) Conrad, Thomas Dr. (1) Dörr, Jan Rafael (1) Forbes, Martin Dr. (2) Henssen, Anton Prof. Dr. med. (12) Kempa, Stefan Dr. (3) Kirchner, Marieluise Dr. (1) Mertins, Philipp Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Röefzaad, Claudia (2) Schwarz, Roland Dr. (2) Wolf, Jana Prof. Dr. (1) (-) Mastrobuoni, Guido Dr. (3) 2021 (2) 2024 (1) AG Müller/Dechend (ECRC) (3) Anchored Signalling (1) Animal Phenotyping (6) Bioinformatics and Omics Data Science (9) Computational Regulatory Genomics (4) Developmental Biology / Signal Transduction (2) (-) Epigenetic Modifications in Neuroblastoma (3) Epigenetic Regulation and Chromatin Architecture (1) Experimental Ultrahigh-Field MR (2) Flow Cytometry (1) Genetics and Genomics of Cardiovascular Diseases (1) Genetics of Congenital Heart Disease (1) Host-microbiome factors in cardiovascular disease (2) Hypertension-caused End-Organ Damage (3) Hypertension-Mediated End-Organ Damage (3) Immune Regulation and Cancer (3) Intracellular Proteolysis (1) Magnetic Resonance (2) Mathematical Modelling of Cellular Processes (2) Molecular Biology of Peptide Hormones (46) Molecular Cardiovascular Research (2) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (1) Organoids (1) Pluripotent Stem Cells (1) Protein Production and Characterization (2) Proteome Dynamics (2) Proteomics and Metabolomics (32) Quantitative Developmental Biology (1) RNA Biology and Posttranscriptional Regulation (7) Systems Biology Imaging (1) Systems Biology of Gene Regulatory Elements (7) 3 Results: Active Filter: Mastrobuoni, Guido Dr.Epigenetic Modifications in Neuroblastoma Sort: Result score Newest to oldest Oldest to newest March 01, 2021 / Int J Cancer Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma B. Arlt C. Zasada K. Baum J. Wuenschel G. Mastrobuoni M. Lodrini K. Astrahantseff A. Winkler J.H. Schulte S. Finkler M. Forbes P. Hundsdoerfer D. Guergen J. Hoffmann J. Wolf A. Eggert S. Kempa H.E. Deubzer June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer May 01, 2024 / Cancers L-glyceraldehyde inhibits neuroblastoma cell growth via a multi-modal mechanism on metabolism and Signaling M. Forbes R. Kempa G. Mastrobuoni L. Rayman M. Pietzke S. Bayram B. Arlt A. Spruessel H.E. Deubzer S. Kempa
March 01, 2021 / Int J Cancer Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma B. Arlt C. Zasada K. Baum J. Wuenschel G. Mastrobuoni M. Lodrini K. Astrahantseff A. Winkler J.H. Schulte S. Finkler M. Forbes P. Hundsdoerfer D. Guergen J. Hoffmann J. Wolf A. Eggert S. Kempa H.E. Deubzer
June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer
May 01, 2024 / Cancers L-glyceraldehyde inhibits neuroblastoma cell growth via a multi-modal mechanism on metabolism and Signaling M. Forbes R. Kempa G. Mastrobuoni L. Rayman M. Pietzke S. Bayram B. Arlt A. Spruessel H.E. Deubzer S. Kempa